Ivana Knežević

ORCID：0000-0002-6441-7601

发表论文 112 篇 · 总被引 4421 次 · h-index 27

代表论文

• WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community (2021 · The Lancet Microbe · 被引 146)
• Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience (2022 · BioDrugs · 被引 46)
• A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells (2021 · npj Vaccines · 被引 41)
• WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20–22 April 2021 (2022 · Emerging Microbes & Infections · 被引 33)
• WHO guidelines on biosimilars: Toward improved access to safe and effective products (2023 · Annals of the New York Academy of Sciences · 被引 24)
• Availability and use of Standards in vaccine development (2023 · npj Vaccines · 被引 19)